Patent · US Active

Enantioselective synthesis of 13-oxotricyclo[8.2.1.0.3,8] trideca-3(8),4,6-triene-5-carboxylates

US7759492B2 · kind B2 · utility

0Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 17, 2005
Grant dateJul 20, 2010
Priority date
Expiry dateFeb 20, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2603/80
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

An enantioselective route to compounds of formula I is disclosed:The compounds of formula I are key intermediates in the synthesis of compounds useful in treatment of Alzheimer's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.